Cargando…
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, which originates from the mesothelial cells of the pleura and is associated with asbestos exposure. In light of its aggressive nature, late diagnosis and dismal prognosis, there is an urgent need for identification of biomarkers i...
Autores principales: | Ferrari, Luca, Carugno, Michele, Mensi, Carolina, Pesatori, Angela Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146237/ https://www.ncbi.nlm.nih.gov/pubmed/32318342 http://dx.doi.org/10.3389/fonc.2020.00445 |
Ejemplares similares
-
Identification of a new potential plasmatic biomarker panel for the diagnosis of malignant pleural mesothelioma
por: Ferrari, Luca, et al.
Publicado: (2022) -
Pleural mesothelioma in a circus worker
por: Mensi, Carolina, et al.
Publicado: (2021) -
Asbestos Exposure in Patients with Malignant Pleural Mesothelioma included in the PRIMATE Study, Lombardy, Italy
por: Spinazzè, Andrea, et al.
Publicado: (2022) -
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019) -
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)